X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (44) 44
humans (40) 40
immunotherapy (29) 29
hematology (24) 24
oncology (23) 23
female (22) 22
immunology (22) 22
transplantation (21) 21
adult (17) 17
cancer (17) 17
leukemia (17) 17
male (17) 17
stem cells (16) 16
middle aged (15) 15
hemic and lymphatic diseases (13) 13
t-lymphocytes, cytotoxic - immunology (12) 12
care and treatment (11) 11
chronic myelogenous leukemia (11) 11
hla-a2 antigen - immunology (10) 10
leukemia, myeloid, acute - therapy (10) 10
t cells (10) 10
acute myeloid-leukemia (9) 9
animals (9) 9
antigen (9) 9
breast cancer (9) 9
cross-presentation (9) 9
fludarabine (9) 9
leukemia, myeloid, acute - immunology (9) 9
lymphocytes (9) 9
treatment outcome (9) 9
versus-host-disease (9) 9
aged (8) 8
aml (8) 8
antigens (8) 8
cell line, tumor (8) 8
expression (8) 8
hematology, oncology and palliative medicine (8) 8
mice (8) 8
peptides - immunology (8) 8
pr1 (8) 8
stem-cell transplantation (8) 8
analysis (7) 7
bone-marrow-transplantation (7) 7
cytotoxic t-lymphocytes (7) 7
health aspects (7) 7
immune response (7) 7
immunity (7) 7
myeloblastin - immunology (7) 7
prognosis (7) 7
acute myeloid leukemia (6) 6
antigens, neoplasm - immunology (6) 6
breast neoplasms - immunology (6) 6
cytotoxicity, immunologic (6) 6
histocompatibility antigens (6) 6
hla histocompatibility antigens (6) 6
leukemia, myeloid, acute - pathology (6) 6
lymphocytes t (6) 6
neutrophil elastase (6) 6
peptides (6) 6
survival analysis (6) 6
t-lymphocytes, cytotoxic - metabolism (6) 6
transplantation, homologous (6) 6
vaccination (6) 6
young adult (6) 6
adaptive immunity (5) 5
allogeneic stem cell transplantation (5) 5
cell biology (5) 5
clinical trials (5) 5
colony-stimulating factor (5) 5
dendritic cells (5) 5
epitopes, t-lymphocyte - immunology (5) 5
hematopoietic stem cell transplantation - adverse effects (5) 5
hematopoietic stem cell transplantation - methods (5) 5
hematopoietic stem cells (5) 5
histocompatibility antigen hla (5) 5
hla-a2 antigen - metabolism (5) 5
medical research (5) 5
myeloid leukemia (5) 5
peptide fragments - immunology (5) 5
stem cell transplantation (5) 5
vaccines (5) 5
abridged index medicus (4) 4
antigens, neoplasm - metabolism (4) 4
busulfan (4) 4
cancer vaccines - therapeutic use (4) 4
chemotherapy (4) 4
chimerism (4) 4
conditioning regimen (4) 4
cytotoxicity (4) 4
development and progression (4) 4
disease-free survival (4) 4
elastase (4) 4
epitopes - immunology (4) 4
graft vs host disease - etiology (4) 4
graft vs host disease - prevention & control (4) 4
hematopoietic stem cell transplantation (4) 4
immunotherapy, adoptive (4) 4
leukemia, myeloid, acute - mortality (4) 4
leukocyte elastase - immunology (4) 4
leukocyte elastase - metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


OncoImmunology, ISSN 2162-4011, 04/2013, Volume 2, Issue 4, p. e23442
Cathepsin G (CG) is a serine protease normally found within the azurophil granules of neutrophils. CG is expressed during the early stages of normal myeloid... 
AML | protease | leukemia | granule | myeloid | immunotherapy | cathepsin G | antigen | azurophil | target | Antigen | Target | Azurophil | Protease | Immunotherapy | Leukemia | Cathepsin G | Granule | Myeloid | ONCOLOGY | IMMUNOLOGY | Author's View
Journal Article
Cancer Research, ISSN 0008-5472, 10/2017, Volume 77, Issue 19, pp. 5374 - 5383
Early-phase clinical trials evaluating CD8(+) T cell-eliciting, HER2-derived peptide vaccines administered to HER2(+) breast cancer patients in the adjuvant... 
IMMUNE-COMPLEXES | RESPONSES | FC-GAMMA RECEPTORS | ONCOLOGY | IN-VIVO | ANTIGEN PRESENTATION | INDUCTION | EXPRESSION | PROTOONCOGENE | CD8(+) T-CELLS | BREAST | T-Lymphocytes, Cytotoxic - immunology | Cell Proliferation | Trastuzumab - therapeutic use | Breast Neoplasms - immunology | Dendritic Cells - immunology | Humans | Receptor, ErbB-2 - metabolism | Mice, Transgenic | Breast Neoplasms - drug therapy | Breast Neoplasms - metabolism | Cancer Vaccines - therapeutic use | Vaccines, Subunit - therapeutic use | Animals | Female | Mice | Mice, Inbred BALB C | Ovarian Neoplasms - metabolism | Receptor, ErbB-2 - immunology | Tumor Cells, Cultured | CD8-Positive T-Lymphocytes - immunology | Ovarian Neoplasms - drug therapy | Apoptosis | Ovarian Neoplasms - immunology | Flow cytometry | Therapy | Animal models | CD8 antigen | Vaccination | Clinical trials | Cytotoxicity | Lymphocytes T | Vaccines | Immunity | Cell activation | Lymphocytes | Immune system | Medical research | Antigen presentation | Immune response | Dendritic cells | Granulocyte-macrophage colony-stimulating factor | Breast cancer | T cell receptors | Adaptive immunity | Patients | ErbB-2 protein | Fc receptors | Cytometry | Monoclonal antibodies | Antitumor activity | Trastuzumab | Cancer | trastuzumab | breast cancer | dendritic cells | cross-presentation | HER2
Journal Article
Pharmacological Reviews, ISSN 0031-6997, 10/2016, Volume 68, Issue 4, pp. 1014 - 1025
The use of antibodies that target immune checkpoint molecules on the surface of T-lymphocytes and/or tumor cells has revolutionized our approach to cancer... 
MULTIPLE-MYELOMA | CTLA-4 BLOCKADE | LUNG-CANCER | REFRACTORY HODGKINS LYMPHOMA | COSTIMULATORY MOLECULES | PHARMACOLOGY & PHARMACY | ACUTE MYELOID-LEUKEMIA | MODIFIED T-CELLS | STEM-CELL TRANSPLANTATION | DEATH LIGAND 1 | VERSUS-HOST-DISEASE
Journal Article
Blood, ISSN 0006-4971, 09/2010, Volume 116, Issue 11, pp. 1824 - 1825
In this issue of Blood , Goodyear and colleagues show that CD8 T-cell immunity against melanoma-associated antigen (MAGE)—a cancer testis antigen (CTA) not... 
Inside Blood
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 6/2016, Volume 65, Issue 6, pp. 741 - 751
Journal Article
PLoS ONE, ISSN 1932-6203, 2010, Volume 5, Issue 7, p. e11770
...Author(s): Shreya Kanodia 1, Eric Wieder 1, Sijie Lu 1, Moshe Talpaz 2, Gheath Alatrash 1, Karen Clise-Dwyer 1, Jeffrey J. Molldrem 1,* Introduction... 
CD34(+) CELLS | IN-VITRO | STEM-CELLS | DENDRITIC CELLS | ALPHA THERAPY | BIOLOGY | ABL GENOMIC REARRANGEMENT | SERINE-PROTEASE | IMATINIB MESYLATE | CHRONIC MYELOID-LEUKEMIA | LYMPHOCYTES | T-Lymphocytes, Cytotoxic - immunology | Peptides - chemistry | Humans | Middle Aged | Peptides - immunology | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Male | Interferon-gamma - metabolism | Remission Induction | Interferon-alpha - administration & dosage | Interferon-alpha - urine | Flow Cytometry | Peptides - chemical synthesis | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Adult | Female | Cytogenetic Analysis | HLA-A2 Antigen - metabolism | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - immunology | Histocompatibility antigens | Peptides | Immunotherapy | HLA histocompatibility antigens | Interferon | B cells | Biological response modifiers | T cells | CD57 antigen | Cell proliferation | CC chemokine receptors | Transplants & implants | Anergy | Leukemia | CD45RA antigen | Proteinase | Cytotoxicity | Lymphocytes T | Kinases | CD28 antigen | Cancer therapies | Immunity | Cell growth | Immunology | Lymphocytes | Peripheral blood | Remission | Elastase | Protein-tyrosine kinase | Tyrosine | Antigens | Immunological memory | Memory cells | Imatinib | Cytokines | Dendritic cells | Myeloid leukemia | CCR7 protein | T cell receptors | Chronic myeloid leukemia | Patients | Studies | γ-Interferon | Stem cells | Histocompatibility antigen HLA | Proteinase 3
Journal Article
Oncotarget, ISSN 1949-2553, 2018, Volume 9, Issue 4, pp. 4280 - 4281
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2012, Volume 18, Issue 12, pp. 1835 - 1844
Journal Article
OncoImmunology, ISSN 2162-4011, 04/2014, Volume 3, Issue 4, p. e28325
Early clinical trials investigating monoclonal antibodies targeting the T-cell inhibitory receptor programmed cell death 1 (PD-1) and its ligand PD-L1 have... 
PD-L1 | triple negative breast cancer | PI3K | biomarker | immunotherapy | Biomarker | Immunotherapy | Triple negative breast cancer | ONCOLOGY | SAFETY | ANTIBODY | IMMUNOLOGY
Journal Article
Cancer, ISSN 0008-543X, 11/2016, Volume 122, Issue 21, pp. 3316 - 3326
Journal Article